Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

News Industry News

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

November 02, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Conference News ACC 2016

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

Todd Neale

April 04, 2016

News Industry News

Boston Scientific Announces Scheduled Presentations At TCT 2015

October 08, 2015

News Daily News

After Years of Scrutiny, Watchman Ready for Prime Time

April 03, 2015

News Daily News

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Todd Neale

February 17, 2015

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

Yael L. Maxwell

June 07, 2013

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

Yael L. Maxwell

May 17, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

News Daily News

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Yael L. Maxwell

April 12, 2013

Advertisement

Initial Results of LAA Closure Device for Stroke Prevention in Patients with Atrial Fibrillation Demonstrate Device Safety and Low Rates of Major Adverse Events

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

New-Generation Watchman FLX Device Pulled From European Shelves Over Embolism Concerns

Boston Scientific Announces Scheduled Presentations At TCT 2015

After Years of Scrutiny, Watchman Ready for Prime Time

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

Oclusión de LAA más rentable que la warfarina y que el dabigatran para pacientes con fibrilación auricular

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content